Transient splenium lesions in presurgical epilepsy patients: Incidence and pathogenesis

Neuroradiology

Volumn 48, Issue 7, 2006, Pages 443-448

  Nelles, Michael ^a   Bien, C G ^a   Kurthen, M ^a   von Falkenhausen, M ^a   Urbach, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Epilepsy; MRI; Splenium

Indexed keywords

ALKYLATING AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITALOPRAM; OLANZAPINE;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN SCINTISCANNING; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FLUID BALANCE; GRANULAR CELL TUMOR; HUMAN; HYPERNATREMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PATHOGENESIS; PATHOPHYSIOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROVOCATION TEST; SCHIZOPHRENIA; SURGICAL TECHNIQUE;

ADULT; ANTICONVULSANTS; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; WITHHOLDING TREATMENT;

EID: 33745601964     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-006-0080-5     Document Type: Article

References (36)

1. Urbach H, Hattingen J, von OJ, Luyken C, Clusmann H, Kral T, Kurthen M, Schramm J, Blumcke I, Schild HH (2004) MR imaging in the presurgical workup of patients with drug-resistant epilepsy. AJNR Am J Neuroradiol 25:919-926
2. Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, Han MH, Lee SK (1999) Focal lesion in the splenium of the corpus callosum in epileptic patients: Antiepileptic drug toxicity? AJNR Am J Neuroradiol 20:125-129
3. Polster T, Hoppe M, Ebner A (2001) Transient lesion in the splenium of the corpus callosum: Three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 70:459-463
4. Cohen-Gadol AA, Britton JW, Jack CR Jr, Friedman JA, Marsh WR (2002) Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. Case report and review of the literature. J Neurosurg 97:714-717
5. Oster J, Doherty C, Grant PE, Simon M, Cole AJ (2003) Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 44:852-854
6. Mirsattari SM, Lee DH, Jones MW, Blume WT (2003) Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 60:1838-1841
7. Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K (2003) Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: Evaluation by diffusion-weighted MR imaging. Eur Radiol 13:1902-1906
8. Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK (2005) Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 62:433-437
9. Friese SA, Bitzer M, Freudenstein D, Voigt K, Kuker W (2000) Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 42:795-802
10. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y (2004) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63:1854-1858
11. Nasrallah K, Silver B (2005) Hyponatremia associated with repeated use of levetiracetam. Epilepsia 46:972-973
12. Arnaout MS, Antun FP, Ashkar K (2001) Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia. Hum Psychopharmacol 16:279-281
13. Horak EL, Jenkins AJ (2005) Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. J Forensic Sci 50:679-681
14. Ogura H, Takaoka M, Kishi M, Kimoto M, Shimazu T, Yoshioka T, Sugimoto H (1998) Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 19:1144-1145
15. Signorini E, Lucchi S, Mastrangelo M, Rapuzzi S, Edefonti A, Fossali E (2000) Central nervous system involvement in a child with hemolytic uremic syndrome. Pediatr Nephrol 14:990-992
16. Kobata R, Tsukahara H, Nakai A, Tanizawa A, Ishimori Y, Kawamura Y, Ushijima H, Mayumi M (2002) Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: Value of diffusion-weighted imaging. J Comput Assist Tomogr 26:825-828
17. Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y (2004) Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: A case report and literature review. AJNR Am J Neuroradiol 25:798-802
18. Hlaihel C, Gonnaud PM, Champin S, Rousset H, Tran-Minh VA, Cotton F (2005) Diffusion-weighted magnetic resonance imaging in Marchiafava-Bignami disease: Follow-up studies. Neuroradiology 47:520-524
19. Kobuchi N, Tsukahara H, Kawamura Y, Ishimori Y, Ohshima Y, Hiraoka M, Hiraizumi Y, Ueno M, Mayumi M (2003) Reversible diffusion-weighted MR findings of Salmonella enteritidis-associated encephalopathy. Eur Neurol 49:182-184
20. Kato Z, Kozawa R, Hashimoto K, Kondo N (2003) Transient lesion in the splenium of the corpus callosum in acute cerebellitis. J Child Neurol 18:291-292
21. Tha KK, Terae S, Sugiura M, Nishioka T, Oka M, Kudoh K, Kaneko K, Miyasaka K (2002) Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand 106:379-386
22. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J (1998) High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 280:1920-1925
23. Wong SH, Turner N, Birchall D, Walls TJ, English P, Schmid ML (2004) Reversible abnormalities of DWI in high-altitude cerebral edema. Neurology 62:335-336
24. Oaklander AL, Buchbinder BR (2005) Pregabalin-withdrawal encephalopathy and splenial edema: A link to high-altitude illness? Ann Neurol 58:309-312
25. Takayama H, Kobayashi M, Sugishita M, Mihara B (2000) Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg 102:135-139
26. Cordoliani YS, Sarrazin JL, Felten D, Caumes E, Leveque C, Fisch A (1998) MR of cerebral malaria. AJNR Am J Neuroradiol 19:871-874
27. Mito Y, Yoshida K, Kikuchi S (2002) Measles encephalitis with peculiar MRI findings. Neurol Med 56:251-256
28. Yamashita N, Tsukahara H, Kawamura Y, et al (2002) Reversible MR findings of Salmonella enteritidis-associated encephalopathy (in Japanese). Infect Immun Child 14:57
29. Kieburtz KD, Ketonen L, Zettelmaier AE, Kido D, Caine ED, Simon JH (1990) Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol 47:643-645
30. Gass A, Birtsch G, Olster M, Schwartz A, Hennerici MG (1998) Marchiafava-Bignami disease: Reversibility of neuroimaging abnormality. J Comput Assist Tomogr 22:503-504
31. Kawamura M, Shiota J, Yagishita T, Hirayama K (1985) Marchiafava-Bignami disease: Computed tomographic scan and magnetic resonance imaging. Ann Neurol 18:103-104
32. Chang KH, Cha SH, Han MH, Park SH, Nah DL, Hong JH (1992) Marchiafava-Bignami disease: Serial changes in corpus callosum on MRI. Neuroradiology 34:480-482
33. Caparros-Lefebvre D, Pruvo JP, Josien E, Pertuzon B, Clarisse J, Petit H (1994) Marchiafava-Bignami disease: Use of contrast media in CT and MRI. Neuroradiology 36:509-511
34. Ruiz-Martinez J, Martinez Perez-Balsa A, Ruibal M, Urtasun M, Villanua J, Marti Masso JF (1999) Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology 41:40-43
35. Gambini A, Falini A, Moiola L, Comi G, Scotti G (2003) Marchiafava-Bignami disease: Longitudinal MR imaging and MR spectroscopy study. AJNR Am J Neuroradiol 24:249-253
36. Mendelsohn DB, Levin HS, Harward H, Bruce D (1992) Corpus callosum lesions after closed head injury in children: MRI, clinical features and outcome. Neuroradiology 34:384-388